drugset / Trial / NCT05814939
Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
RandomizedSequentialDouble-blindTreatment
Summary
This clinical trial is a multicenter, randomized, double-blind, controlled phase II clinical study.
Timeline
- Start
- 2023-04-26
- Primary completion
- 2024-05-11
- Completion
- 2024-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tofacitinib | Small molecule | — | — |
| Subject | VC005 | Unknown | — | — |